Work

Supplementary Table S3 from FDA Approval Summary: Blinatumomab for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy

Year: 2025
Type: supplementary-materials
Abstract: Table S3 shows the demographics of the randomized population for Study 20120215.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4415212160
Cites:
Cited by:
Related to: 10